Each of our bodies contains an intricate network of pathways which are involved in regulating physiological and cognitive processes, or the way our bodies intrinsically function and behave. One such network that has recently gained interest is the Endocannabinoid system, which is expressed throughout our central and peripheral nervous system, as well as end organ tissues and immune systems. Our bodies signal and interact with this system via endocannabinoids, or cannabinoid neurotransmitters that are expressed inside each of us. So far, two relevant endocannabinoid receptors have been identified which interact with these signaling molecules. The primary receptor targets, CB1 and CB2, are found predominantly in the brain and nervous system, as well as peripheral organs, tissues, and immune systems, respectively. Studies have shown complex interactions and relationships between the endocannabinoid system and our bodies ability to maintain homeostasis (balance), as well as potential function in appetite stimulation and suppression, energy storage and metabolism, stress response, pain suppression, disruption of certain cancer cell growth, and sleep.
Cannabidiol (CBD) is one of hundreds of cannabinoids found in the cannabis science and technology sativa plant, which can range from industrial hemp to marijuana, depending on the total THC content. Unlike THC, CBD has no psychotropic or mind altering effects, therefore promoting its use as a novel treatment method for a variety of ailments without subjecting the patient to the ‘high’ associated with THC containing marijuana. The activity of these external messengers have been studied with fervor more recently, and are being investigated in a similar manner as many pharmaceutical drugs. In fact, there are currently a number of pharmaceutical synthetic cannabinoid drugs on the market to help control appetite, chemotherapy related nausea, pain related to multiple sclerosis, and rare refractory seizure disorders.
CBD is one of the most interesting and popular topics in health science over the past couple of years; due in part to its reported health benefits and reduced legal scrutiny. CBD is a completely non-psychoactive component found in the Cannabis science and technology Sativa plant, with potential health benefits spanning a wide range of afflictions. Its primary mechanism of action is purported to be related to its anti-inflammatory and antioxidant properties, but it also works through a highly complex signaling network, which helps to modulate a variety of bodily functions through our own endocannabinoid system. Given its previously unfavorable legal status, these cannabinoids have not been used widely in healthcare or cosmetics, but this trend is rapidly changing. With new FDA approved indications for the use of CBD in an expanding variety of medical problems, as well as numerous reported cosmetic benefits in topical applications, the CBD industry is booming. At Enradia CBD, we have met with a number of chemists, physicians, and labs to determine the most effective and efficient means to deliver the benefits of CBD in a quality line of products that will leave you wanting more.